Behnke N, Müller W, Neumann J, Schmitz W, Scholz H, Stein B
Abteilung Allgemeine Pharmakologie, Universitäts-Krankenhaus Eppendorf, Universität Hamburg, Federal Republic of Germany.
J Pharmacol Exp Ther. 1990 Sep;254(3):1017-23.
The antagonism by the A1-adenosine receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) and the A2-adenosine receptor antagonist [9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolo (1,5-c)quinazolin-5-imine] (CGS 15943A) of the effects of the A1-adenosine receptor agonist (-)-N6-phenylisopropyladenosine (R-PIA) and the A2-adenosine receptor agonist 5'-N-ethyl-carboxamideadenosine (NECA) in the presence of isoprenaline on contractile response and cyclic AMP (cAMP) content in cardiomyocytes from guinea pig cardiac ventricles were studied. In electrically driven (1 Hz) guinea pig ventricular cardiomyocytes R-PIA concentration-dependently (0.0001-100 microM) reduced the stimulatory effects of isoprenaline (0.01 microM) on contractile response and on cAMP content. The A1-adenosine receptor antagonist DPCPX (0.3 microM) antagonized the effects of R-PIA on contractile reponse and on cAMP content, whereas the A2-adenosine receptor antagonist CGS 15943A (0.01 microM) was ineffective. NECA (0.0001-100 microM) reduced the effects of isoprenaline (0.01 microM) on contractile response to about the same extent as R-PIA. However, NECA did not change cAMP content. DPCPX (0.3 microM) antagonized the effects of NECA on contractile response and evoked a cAMP-increasing effect of NECA, which was 38% of the isoprenaline value at most. In contrast, CGS 15943A did not affect the reduction of contractile response induced by NECA, whereas CGS 15943A revealed a cAMP-decreasing effect of NECA (0.1-10 microM). This study provides functional evidence that both, cAMP-decreasing A1- and cAMP-increasing A2-adenosine receptors are present on ventricular cardiomyocytes.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了A1 - 腺苷受体拮抗剂1,3 - 二丙基 - 8 - 环戊基黄嘌呤(DPCPX)和A2 - 腺苷受体拮抗剂[9 - 氯 - 2 - (2 - 呋喃基)- 5,6 - 二氢 - 1,2,4 - 三唑并(1,5 - c)喹唑啉 - 5 - 亚胺](CGS 15943A)对A1 - 腺苷受体激动剂( - )- N6 - 苯异丙基腺苷(R - PIA)和A2 - 腺苷受体激动剂5'- N - 乙基 - 甲酰胺腺苷(NECA)在异丙肾上腺素存在下对豚鼠心室肌细胞收缩反应和环磷酸腺苷(cAMP)含量影响的拮抗作用。在电驱动(1Hz)的豚鼠心室肌细胞中,R - PIA浓度依赖性地(0.0001 - 100μM)降低了异丙肾上腺素(0.01μM)对收缩反应和cAMP含量的刺激作用。A1 - 腺苷受体拮抗剂DPCPX(0.3μM)拮抗了R - PIA对收缩反应和cAMP含量的作用,而A2 - 腺苷受体拮抗剂CGS 15943A(0.01μM)无效。NECA(0.0001 - 100μM)对异丙肾上腺素(0.01μM)收缩反应的降低作用与R - PIA大致相同。然而,NECA并未改变cAMP含量。DPCPX(0.3μM)拮抗了NECA对收缩反应的作用,并引发了NECA增加cAMP的作用,其最大为异丙肾上腺素作用值的38%。相反,CGS 15943A不影响NECA诱导的收缩反应降低,而CGS 15943A显示NECA(0.1 - 10μM)有降低cAMP的作用。本研究提供了功能性证据,表明心室肌细胞上同时存在降低cAMP的A1 - 腺苷受体和增加cAMP的A2 - 腺苷受体。(摘要截短至250字)